KYNTRA BIO, INC. (KYNB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-60M 0 60M 120M 180M Q2 '21: 24.4M Q3 '21: 156M Q4 '21: 16.5M Q1 '22: 60.8M Q2 '22: 29.8M Q3 '22: 15.7M Q4 '22: 34.4M Q1 '23: 36.2M Q2 '23: 44.3M Q3 '23: 40.1M Q1 '24: 25.4M Q2 '24: 998K Q3 '24: 123K Q4 '24: 3.1M Q1 '25: 2.7M Q2 '25: 1.3M Q3 '25: 1.1M Q4 '25: 1.3M Q1 '26: 3.7M Q2 '26: -1.5M Q3 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-60M 0 60M 120M 180M Q1 '21: 35M Q2 '21: 21.3M Q3 '21: 152.7M Q4 '21: 13.4M Q1 '22: 56.6M Q2 '22: 23M Q3 '22: 11.4M Q4 '22: 29.4M Q1 '23: 32.7M Q2 '23: 38.6M Q3 '23: 35.9M Q1 '24: 4M Q2 '24: 858K Q3 '24: 48K Q1 '25: 2.5M Q2 '25: 1.3M Q3 '25: 1M Q4 '25: 999K Q1 '26: -368K Q2 '26: -1.5M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q3 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '21: 51M Q4 '21: -135.2M Q1 '22: -63M Q2 '22: -78.2M Q3 '22: -93.7M Q4 '22: -66.2M Q1 '23: -76.1M Q2 '23: -88M Q3 '23: -63.5M Q4 '23: -95.1M Q1 '24: -49.2M Q2 '24: -46.4M Q3 '24: -47.7M Q4 '24: -7.1M Q1 '25: -14.9M Q2 '25: -12.1M Q3 '25: -5.4M Q4 '25: -13.5M Q1 '26: -13.8M Q2 '26: -17.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-140M -70M 0 70M 140M 210M Q3 '21: 49.8M Q4 '21: -134.1M Q1 '22: -63.2M Q2 '22: -72.6M Q3 '22: -91.7M Q4 '22: -66.2M Q1 '23: -76.7M Q2 '23: -87.7M Q3 '23: -63.6M Q4 '23: -56.2M Q1 '24: -32.9M Q2 '24: -15.5M Q3 '24: -17.1M Q4 '24: 18M Q1 '25: 4.6M Q2 '25: -7.6M Q3 '25: 200.6M Q4 '25: -14.2M Q1 '26: -15.2M Q2 '26: 12M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

-8M 0 8M 16M 24M Q1 '21: 3.4M Q2 '21: 3.1M Q3 '21: 3.3M Q4 '21: 3.1M Q1 '22: 4.2M Q2 '22: 6.8M Q3 '22: 4.3M Q4 '22: 4.9M Q1 '23: 3.5M Q2 '23: 5.7M Q3 '23: 4.2M Q1 '24: 21.3M Q2 '24: 140K Q3 '24: -75K Q1 '25: 252K Q2 '25: 85K Q3 '25: -58K Q4 '25: 278K Q1 '26: 4.1M Q2 '26: 2K Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q3 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-120M -80M -40M 0 40M 80M 120M Q2 '21: -26.5M Q3 '21: 44.3M Q4 '21: -55M Q1 '22: -8.5M Q2 '22: -33.1M Q3 '22: -51.9M Q4 '22: -52.5M Q1 '23: -101.6M Q2 '23: -110.6M Q3 '23: -84.5M Q4 '23: -18.3M Q1 '24: -59.3M Q2 '24: -39.9M Q3 '24: -8.4M Q4 '24: -30.5M Q1 '25: 2.7M Q2 '25: 12.7M Q3 '25: -1.8M Q1 '26: -13.9M Q2 '26: -4M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Free Cash Flow Quarterly

-120M -80M -40M 0 40M 80M 120M Q2 '21: -28.2M Q3 '21: 42.7M Q4 '21: -56.4M Q1 '22: -10.1M Q2 '22: -34M Q3 '22: -52.7M Q4 '22: -52.8M Q1 '23: -102.2M Q2 '23: -111.6M Q3 '23: -85.2M Q4 '23: -18.6M Q1 '24: -59.3M Q2 '24: -39.9M Q3 '24: -8.5M Q4 '24: -30.6M Q1 '25: 2.7M Q2 '25: 12.7M Q3 '25: -1.9M Q1 '26: -13.9M Q2 '26: -4M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '19: 91.7M Q3 '19: 87M Q2 '20: 89.5M Q3 '20: 93.7M Q2 '21: 92.3M Q3 '21: 92.8M Q1 '22: 93M Q2 '22: 93.5M Q3 '22: 93.8M Q1 '23: 94.7M Q2 '23: 97.7M Q3 '23: 98.2M Q1 '24: 99M Q2 '24: 4M Q3 '24: 4M Q1 '25: 4M Q2 '25: 4M Q3 '25: 4M Q1 '26: 4M Q2 '26: 4M Q3 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-20.00 0.00 20.00 40.00 60.00 Q3 '21: -2.34 Q4 '21: -3.14 Q1 '22: -3.04 Q2 '22: -2.37 Q3 '22: -3.89 Q4 '22: -3.15 Q1 '23: -3.28 Q2 '23: -3.40 Q3 '23: -3.07 Q4 '23: -2.93 Q1 '24: -2.45 Q2 '24: -5.44 Q3 '24: -9.04 Q4 '24: -11.89 Q1 '25: -10.41 Q2 '25: -8.40 Q3 '25: 45.46 Q4 '25: 45.37 Q1 '26: 40.46 Q2 '26: 45.30 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.